No audio available for this content. From left: Esri Program Manager Doug Morgenthaler, Laser Technology Sr. Product Manger Derrick Reish and Eos CTO Jean-Yves Lauture. (Photo: Eos Positioning) The ...
Monoclonal antibodies (mAbs) dominate the biotherapeutic market, with numerous products designed to provide treatments for cancer or immune diseases such as Crohn’s disease, rheumatoid arthritis, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback